ASC-Derived Extracellular Vesicles Suppress Macrophage-Driven Inflammatory Amplification and Contractile Activation

Ji-Seon Lee1, You-Rin Kim1, Dogeon Yoon1

  • 1Burn Institute, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07247, Republic of Korea.

Insights

Adipose stem cell-derived extracellular vesicles (ASC-EVs) can prevent preterm labor by reducing inflammation. These EVs suppress macrophage signaling and uterine smooth muscle cell contraction, offering a potential cell-free therapy.

Area of Science:

  • Reproductive biology
  • Immunology
  • Cell biology

Background:

  • Preterm labor is a leading cause of infant mortality.
  • Infection-induced inflammation triggers uterine contractions, leading to preterm birth.
  • Macrophage activation plays a key role in inflammation-associated preterm labor.

Purpose of the Study:

  • To investigate the therapeutic potential of adipose stem cell-derived extracellular vesicles (ASC-EVs) in preventing preterm labor.
  • To determine the effects of ASC-EVs on macrophage-mediated inflammatory signaling in human uterine smooth muscle cells (HUtSMCs).

Main Methods:

  • An in vitro model using LPS-stimulated macrophages and HUtSMCs was established.
  • Western blotting and immunofluorescence assessed signaling pathway activation (MAPK, NF-κB).
  • Functional assays evaluated calcium flux and collagen gel contraction.

Main Results:

  • LPS-stimulated macrophages induced MAPK and NF-κB activation in HUtSMCs.
  • ASC-EVs significantly attenuated inflammatory signaling and pro-inflammatory cytokine expression (IL-6, IL-8, MCP-1).
  • ASC-EVs suppressed macrophage-conditioned media-induced calcium flux and HUtSMC contraction.

Conclusions:

  • ASC-EVs effectively suppress macrophage-mediated inflammation and uterine contractility.
  • TLR4 signaling in macrophages is crucial for initiating inflammation.
  • ASC-EVs show promise as a cell-free therapeutic for preventing preterm labor.

Related Concept Videos